block grant program, 153–157
enhanced or expanded Medicaid, 148–153, 195, 213–214, 230, 231
expanded CARE Act programs, 144–145
HAART modeling for evaluation of, 214–216
inputs for modeling, 217–225
Medicare expansion, 145–148, 195
projected enrollment, 224–225
projected utilization, 223–224
prospects, 174–175
range of, 15–16, 141, 142, 213
sensitivity analyses, 234–243
state participation, 142–144
See also HIV Comprehensive Care Program
American Public Health Association, 47
Antiretroviral drugs
access disparities, 129–130
alternative therapies, 46
for children, 90
technical evolution, 42–43
See also Highly active antiretroviral therapy
Anxiety disorders
adherence to HIV treatment and, 91
Assessment
adherence prediction, 49
depression, 55
insurance status and time of diagnosis, 274
role of primary care, 98
Asymptomatic infection, 40–41
At-risk populations, 37
implications for health care delivery, 50
Automobile restraints, 187
Awareness of HIV status, 156, 181, 218, 226
B
Bailey Boushay House, 333
Barriers to care
in CARE Act programs, 118–122, 300
conflicting goals among programs, 133–134
coordination among programs and, 127–129, 136, 268, 305–306, 328
cost of care, 132–133
in current system, 6, 14, 19, 27, 133–134, 280–283, 304–307
in Medicaid, 12, 17, 109–114, 132–133, 291–293
in private insurance programs, 107–109, 301, 302–303
provider reimbursement, 19, 111, 325–326
sources of, 129
for substance abusers, 58–59, 313, 318–323, 325–327, 330–332
for women of color, 59
See also Access to care
Bipolar disorder, 251
Block grants
advantages, 154
disadvantages, 155–157
structure, 153–154
substance abuse treatment, 324
C
Cancer, 44
Candidiasis, 42
CARE Act. See Ryan White CARE Act
Care coordination model of service, 170
Care-seeking behavior
cost of care and, 132
substance abuse and, 58, 94, 319
Case management, 127
CARE Act coverage, 298–299
Centers of Excellence model, 170
definition, 96
delivery models, 96
HAART utilization and, 224
modeling service needs, 223–224
CD4 lymphocyte levels
depression effects, 93–94